Cascade Financial Partners, LLC Novartis Ag Transaction History
Cascade Financial Partners, LLC
- $832 Billion
- Q2 2025
A detailed history of Cascade Financial Partners, LLC transactions in Novartis Ag stock. As of the latest transaction made, Cascade Financial Partners, LLC holds 5,205 shares of NVS stock, worth $617,052. This represents 0.08% of its overall portfolio holdings.
Number of Shares
5,205
Previous 5,080
2.46%
Holding current value
$617,052
Previous $566 Million
11.22%
% of portfolio
0.08%
Previous 0.07%
Shares
5 transactions
Others Institutions Holding NVS
# of Institutions
1,552Shares Held
142MCall Options Held
1.64MPut Options Held
1.82M-
Dodge & Cox San Francisco, CA11.8MShares$1.4 Billion0.81% of portfolio
-
Primecap Management CO Pasadena, CA10.4MShares$1.23 Billion1.03% of portfolio
-
Dimensional Fund Advisors LP Austin, TX8.61MShares$1.02 Billion0.25% of portfolio
-
Morgan Stanley New York, NY7.06MShares$836 Million0.06% of portfolio
-
Ken Fisher Fisher Asset Management, LLC | Camas, Wa6.76MShares$802 Million0.33% of portfolio
About NOVARTIS AG
- Ticker NVS
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,151,000,064
- Market Cap $255B
- Description
- Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...